Logo
Please rotate your device

Landscape orientation recommended.

Menu

No results found.

4005
Sumitomo Chemical Company, Limited – TYO
Weekly Share Price & Valuation Overview
Market Overview
Open
362.5000
Close
386.1000
High
403.6000
Low
358.8000
Trend
0.50163

Sumitomo Chemical Company, Limited

Japan • TYO - Tokyo Stock Exchange • 4005 • Currency: JPY

Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, synthetic resin processed products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.

Key strengths
  • Earnings growth ≥10% supports improving profitability trajectory.
Potential weaknesses
  • Quick ratio <0.8 — tight near-term liquidity without inventory.
  • Debt/EBITDA >4 — elevated leverage vs earnings capacity.
Scale & Structure Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
Market Cap Total equity value of the company (share price × shares outstanding).
JPY 657.42B
Enterprise Value Operating value: market cap + total debt − cash.
JPY 1.88T
Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
JPY 2.52T
Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
JPY 717.34B
EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
JPY 306.57B
Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
JPY 1.54K
EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
23.57
Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
2.99%
Shares Outstanding
1.64B
Float Shares
1.61B
Implied Shares Outstanding
1.64B
Profitability & Efficiency TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
6.70%
EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
12.16%
Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
28.46%
Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
0.38%
ROA Return on assets: net income ÷ total assets.
3.07%
ROE Return on equity: net income ÷ shareholder equity.
1.11%
Growth Growth rates are YoY unless labeled QoQ.
Revenue Growth Year-over-year revenue growth.
-14.10%
Earnings Growth (YoY) Strong Year-over-year earnings growth.
30.00%
Liquidity & Solvency Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
0.77
Debt to Equity Total debt ÷ shareholder equity; leverage.
1.18
Total Cash Cash and equivalents.
JPY 202.65B
Total Debt Short + long-term interest-bearing debt.
JPY 1.25T
Net Debt Total debt − cash (negative = net cash).
JPY 1.05T
Debt / EBITDA Leverage relative to operating earnings; lower is safer.
4.07
Cash Flow Shown only when internally consistent; margins are TTM.
Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
JPY 269.28B
Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
JPY 18.90B
OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
10.68%
FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
0.75%
Cash Conversion (OpCF/EBITDA)
0.88
Sharemaestro House View
Confidence: 1 Sharemaestro internal conviction (0–3, higher is better). Risk: 1 Sharemaestro internal risk profile (0–3, higher is safer). Operational: 1 Operational quality/consistency (0–3, higher is better). Composite Score: 1 Overall internal composite (0–3, higher is better). Suggested Allocation: 1.67% Indicative portfolio weighting suggestion based on house view.
Structural Insights (experimental)
Ownership & Liquidity
Free Float Proportion of shares available for public trading. 98.1%
Insiders Shares held by company insiders (officers, directors). 2.4%
Institutions Shares held by institutions (funds, pensions). 39.7%
Capital Structure
Potential Dilution Increase in share count if options/convertibles exercise.
None detected
Net Debt Total debt − cash (negative = net cash).
JPY 1.05T
41.5% of revenue Net debt relative to revenue — debt load vs business scale.
Resilience Score 0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating. 22
Methodology Notes
  • Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
  • Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 10:03

Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.

AI generated insights not available yet. Sign in to generate the snapshot.